Clinical Trial Reimbursement in the U.S.: FAQs for MedTech Companies
Published on: 19/03/2025
A clear FAQ guide on how MedTech startups can secure Medicare reimbursement for clinical trials—and when it’s worth it.
Evidence Planning
A clear FAQ guide on how MedTech startups can secure Medicare reimbursement for clinical trials—and when it’s worth it.
QALYs are essential in Europe—but not in the U.S. Here's what really drives MedTech coverage decisions and how to pivot.
New tech payments like NTAP can’t justify long-term pricing. Here’s what MedTech founders need to know.
Learn how payer claims data strengthens medtech value stories without long clinical trials.